SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-091838
Filing Date
2024-08-06
Accepted
2024-08-06 16:15:31
Documents
86
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rckt-20240630.htm   iXBRL 10-Q 1739822
2 EX-31.1 rckt-ex31_1.htm EX-31.1 15630
3 EX-31.2 rckt-ex31_2.htm EX-31.2 15755
4 EX-32.1 rckt-ex32_1.htm EX-32.1 11854
5 GRAPHIC img173862134_0.jpg GRAPHIC 63627
6 GRAPHIC img173862134_1.jpg GRAPHIC 140884
  Complete submission text file 0000950170-24-091838.txt   8789500

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rckt-20240630.xsd EX-101.SCH 1321778
88 EXTRACTED XBRL INSTANCE DOCUMENT rckt-20240630_htm.xml XML 1494303
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 241179464
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)